http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101179843-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39558 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57446 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate | 2009-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2012-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2012-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101179843-B1 |
| titleOfInvention | Use of Neurophylline 2 for Diagnosis and Treatment of Gastric Cancer |
| abstract | The present invention is a gastric cancer diagnostic composition comprising an agent for measuring the expression level of the gene (Table 2) that is found to be overexpressed in gastric cancer-derived vascular endothelial cells compared to the normal gastric mucosa, and gastric cancer diagnosis using the same It is about a method.n n n In addition, the present invention relates to a pharmaceutical composition for treating gastric cancer comprising an inhibitor of Neuropilin2.n n n n Neuropilin2, Tumor Endothelial Cells, Gastric Cancer, VEGF |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101818735-B1 |
| priorityDate | 2009-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 274.